Mecanismos moleculares implicados en la respuesta celular al estrés
Universidade de Santiago de Compostela
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (15)
1999
-
Salivary gland is capable of GH synthesis under GHRH stimulation
Journal of Endocrinology, Vol. 160, Núm. 2, pp. 217-222
1995
-
Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats
Neuroendocrinology, Vol. 61, Núm. 5, pp. 552-558
-
Regulation of hypothalamic somatostatin by glucocorticoids
Journal of Steroid Biochemistry and Molecular Biology, Vol. 53, Núm. 1-6, pp. 277-282
1993
-
Clonidine potentiates the growth hormone (GH) response to GH-releasing hormone in norepinephrine synthesis-inhibited rats: Evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin
Neuroendocrinology, Vol. 57, Núm. 6, pp. 1155-1160
-
Glucocorticoids may inhibit growth hormone release by enhancing β-adrenergic responsiveness in hypothalamic somatostatin neurons
Journal of Clinical Endocrinology and Metabolism, Vol. 76, Núm. 2, pp. 439-444
1992
-
Neuroendocrine control of growth hormone secretion in humans
Trends in Endocrinology and Metabolism
1991
-
Clonidine pretreatment modifies the growth hormone secretory pattern induced by shortterm continuous GRF infusion in normal man
Clinical Endocrinology, Vol. 35, Núm. 2, pp. 129-135
-
Evidence that α2-Adrenergic pathways play a major role in growth hormone (GH) neuroregulation: α2-Adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH Response to GH-Releasing Hormone, while α2-Adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men
Journal of Clinical Endocrinology and Metabolism, Vol. 73, Núm. 2, pp. 251-256
-
Role of central dopaminergic pathways in the neural control of growth hormone secretion in normal men: Studies with metoclopramide
Neuroendocrinology, Vol. 53, Núm. 2, pp. 143-149
1990
-
New concepts in the neuroregulation of growth hormone secretion
Arquivos de Medicina, Vol. 3, Núm. 4, pp. 329-338
-
α2-adrenergic agonism enhances the growth hormone (gh) response to gh-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men
Journal of Clinical Endocrinology and Metabolism, Vol. 71, Núm. 6, pp. 1581-1588
1989
-
Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: Does acute hyperglycemia act through hypothalamic release of somatostatin?
Neuroendocrinology, Vol. 49, Núm. 5, pp. 551-554
-
Growth hormone (GH) responsiveness to GHRH in normal adults is not affected by short-term gonadal blockade
Acta Endocrinologica, Vol. 120, Núm. 1, pp. 31-36
-
REASONS FOR THE VARIABILITY IN GROWTH HORMONE (GH) RESPONSES TO GHRH CHALLENGE: THE ENDOGENOUS HYPOTHALAMIC‐SOMATOTROPH RHYTHM (HSR)
Clinical Endocrinology, Vol. 30, Núm. 4, pp. 367-377
1987
-
GROWTH HORMONE AND PROLACTIN SECRETION AFTER GROWTH HORMONE‐RELEASING HORMONE ADMINISTRATION, IN ANOREXIA NERVOSA PATIENTS, NORMAL CONTROLS AND TAMOXIFEN‐PRETREATED VOLUNTEERS
Clinical Endocrinology, Vol. 27, Núm. 5, pp. 517-523